Furthermore, we found that endogenous expression of Spry2 in 15 NPC tissue specimens was prominently reduced in comparison with 15 NP tissue specimens (Figure 6A), demonstrating Spry2 might function as a tumor suppressor in NPC. This evidence concerns the gene SPRY2 and nasopharyngeal carcinoma.